Global Multiplex Assay
At cognitive, a dedicated team has worked on this report, we have disclosed one of the team member involved in the publication and client consultation process for your reference. You can initiate the discussion her via Book an appointment
At cognitive, our research analyst works closely with Multiplex Assay market experts to validate the gathered data and have the expert's opinion available for our clients. You can book a consultation call with our research analyst and industry experts on board (Subject to time availability and paid consultation services)
The base year for the analysis is 2025. Historical data has been considered for the period from 2022 to 2025. The year 2026 is considered as the estimated base for forecasting, with projections covering the period from 2026 to 2034. When we deliver the report that time we updated report data till the purchase date.
From the database of Cognitive, this is an unique identification number of reports and it will also have different reports associated with it.
Report edition's total number of pages for pdf format (Approximate)
Rating and review received by the reader or subscriber of the said report.
Athenaeum Visualization Dashboard: Access your purchased data/Report/Service through a sophisticated, interactive interface. The Athenaeum Dashboard allows you to preview data/reports and store them in a customizable dashboard, enabling you to filter metrics and uncover deeper trends specific to your enterprise needs.
PDF Access: To ensure the highest level of data integrity and confidentiality, your premium report editions are delivered as password-protected PDF files. These are securely shared via email and remain accessible within your dedicated Athenaeum account for future reference.
Versatile Multi-Format Export (Excel & MS Word): We provide the flexibility to integrate our research directly into your internal workflows. Upon request, relevant quantitative data and qualitative insights from your purchased reports can be provided in fully editable Microsoft Excel and Word formats.
Multiple Cloud Accounts: Benefit from a dedicated, encrypted cloud account that ensures your market intelligence is available on-demand. Access your research from any device, at any time, and from any location. Multiple Accounts facilitating seamless collaboration across your collegue or whole organization.
Athenaeum AI Assistant(Value-Added Service): Elevate your research capabilities with Athenaeum AI Assistant, our proprietary 24/7 research assistant. Equivalent in depth to a dedicated research analyst, this AI-driven tool provides round-the-clock data support and instant insights to help you navigate complex market landscapes in real-time.
As Cognitive a market research and consulting firm, we can provide Multiplex Assay market Analysis and consultation services with the help of our data collection processes and Proprietary research methodology called Full Truth. We have in-house team of research analysts and network of industry experts on board. In fact, we provided high-impact consualtion services to the listed client in competitior analysis. As an extension of our bespoke consulting engagements, we also provide access to Proprietary datasets of market analysis publish, making authoritative industry intelligence accessible to the public domain.
Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence. along with Report Access and Athenaeum Dashboard Subscription — Revenue, Volume, Production, Trade Analysis, value chain and supply chain analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022-2025 | Base Year: 2025 | Forecast Period: 2026-2034 |
|---|---|
| Type Segment Analysis | Protein-Based Multiplex Assay, Nucleic Acid-Based Multiplex Assay |
| Application Segment Analysis | Research & Development, Diagnosis |
| Technology Segment Analysis | Flow Cytometry, Fluorescence, Luminescence |
|---|---|
| Regions & Countries Analysis |
|
Share your contact details to receive free updated sample copy/pages of the recently published edition of Multiplex Assay Market Report 2025.
Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence. along with Report Access and Athenaeum Dashboard Subscription — Revenue, Volume, Production, Trade Analysis, value chain and supply chain analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Market Size | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Global Market Size | xxxx | xxxx | xxxx | xxxx |
| Country Market Size | xxxx | xxxx | xxxx | xxxx |
| North Americ Market Size | xxxx | xxxx | xxxx | xxxx |
| Europe Market Size | xxxx | xxxx | xxxx | xxxx |
| Asia Pacific Market Size | xxxx | xxxx | xxxx | xxxx |
| South America Market Size | xxxx | xxxx | xxxx | xxxx |
| Middle East Market Size | xxxx | xxxx | xxxx | xxxx |
| Africa Market Size | xxxx | xxxx | xxxx | xxxx |
Multiplex Assay Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
The multiplex assay is a type of immunoassay technology that uses magnetic beads to measure multiple analytes in a single experiment. It measures all the analytes simultaneously. Multiplex assay is a derivative of enzyme-linked immunosorbent assay (ELISA) that uses beads for binding to the captured antibodies. These assays are efficient and cost-effective ways to analyze multiple biomarkers in a single experiment. Multiplex assays quickly diagnose and monitor infectious diseases. They also monitor drug efficacy and identify potential drug targets. The increasing prevalence of chronic diseases and the rising need for effective clinical diagnostics have led to higher adoption of the multiplex assay market.
Market Dynamics of the Multiplex Assay Market
Chronic diseases like diabetes, cancer, and heart disease are on the rise across the globe. Similarly, the rising prevalence of infectious diseases like malaria, HIV, dengue, and tuberculosis contribute significantly to the market growth of multiplex assays. The technological advancements in multiplex assay testing provide early, effective diagnosis and treatment for such diseases. Multiplex assays also give quicker results, detect the prevailing disease's sensitivity, and simultaneously measure the sample analytes. This test can also be attributed to the rising need for effective clinical diagnostics. As reported by the WHO, chronic diseases are estimated to kill 40 million people annually, which accounts for 70% of mortality globally. Thereby increasing the demand for the multiplex assay testing market.
The initial investment in multiplex assay equipment is high, despite its simultaneous operations. Even though there are long-term savings and potential, the small-scale use of multiplex assays finds them quite expensive to a certain extent. The reagents used in multiplex assays have variable costs and are hence fixed by the suppliers, thereby adding to the total expenditure. Moreover, the maintenance of equipment, its insurance, and laboratory supervision lead to additional costs. These factors tend to hamper the growth of the multiplex assay market.
Impact of the COVID-19 pandemic on the Multiplex Assay Market:
COVID-19 significantly impacted the multiplex assay market. The diagnosis of SARs-CoV-2 was preferably done by the multiplex testing process. This helped in assessing the risk of viral transmission and the presence of SARS-CoV-2 in the collected samples. Moreover, multiple testing was widely adopted during the pandemic due to the increasing prevalence of chronic and infectious diseases. The technical advancements in multiplex assay testing provide early, effective diagnosis and treatment for such diseases. Multiplex assays also give quicker results and detect the prevailing disease's sensitivity. The increasing number of COVID-19 cases highly demanded diagnostic centers for providing better access and precise diagnostic results in delivering patient care and controlling viral transmissions. Therefore, the multiplex assay market was positively impacted and is expected to grow during the forecasted period.
We have various report editions of Multiplex Assay Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Competitive Analysis of the Multiplex Assay Market
The key market players in the multiplex assay market are Luminex Corporation, Bio-Rad Laboratories, Inc., Illumina, Inc., Bio-Techne Corporation, Becton Dickinson and Company, Agilent Technologies, Inc., Meso Scale Diagnostics, Enzo Life Sciences, Inc., and Antigenix America, Inc. These market players focus on innovations and advancements in multiplex assay testing to propel their market growth.
Recent Developments:
In March 2020
The Luminex Corporation received funding from the Biomedical Advanced Research and Development Authority (BARDA). These funds supported the development and testing of an Emergency Use Authorization (EUA) for the ARIES SARs-CoV-2 Assay.
In July 2021
DiaSorin S.p.A announced that it has completed the acquisition of Luminex Corporation for a price of USD 37.00 per share. This corresponded to a total equity value of approximately USD 1.8 billion.
Top Companies Market Share in Multiplex Assay Industry: (In no particular order of Rank)
| Companies | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Bio-Rad Laboratories | xxxx | xxxx | xxxx | xxxx |
| Thermo Fisher Scientific | xxxx | xxxx | xxxx | xxxx |
| Illumina | xxxx | xxxx | xxxx | xxxx |
| Luminex Corporation | xxxx | xxxx | xxxx | xxxx |
| Abcam | xxxx | xxxx | xxxx | xxxx |
| Seegene | xxxx | xxxx | xxxx | xxxx |
| Merck KGaA | xxxx | xxxx | xxxx | xxxx |
| QIAGEN | xxxx | xxxx | xxxx | xxxx |
| PerkinElmer | xxxx | xxxx | xxxx | xxxx |
| R&D Systems | xxxx | xxxx | xxxx | xxxx |
| Assay Genie | xxxx | xxxx | xxxx | xxxx |
| Becton | xxxx | xxxx | xxxx | xxxx |
| Dickinson and Company | xxxx | xxxx | xxxx | xxxx |
*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)
Request Any Company Profile for Preview Purpose OR Data Validation!
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Regional analysis
North America is projected to have the largest market share during the forecast period.
Globally, the multiplex assay market is segmented by region into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. The North American region is projected to have the largest market share due to the rising prevalence of chronic diseases like cancer in this region and growing investments in healthcare infrastructure. As reported in the statistics by the Government of Canada, about 229,100 people in Canada were diagnosed with cancer. Similarly, the prevalence of breast cancer in the Canadian region affected almost every one out of ten women. The rising burden of cancer majorly needs early-stage diagnosis and testing like multiplex assays, thereby increasing the growth of its market in this region.
The current report Scope analyzes Multiplex Assay Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Multiplex Assay Market is witnessing significant growth in the near future.
In 2023, the Protein-Based Multiplex Assay segment accounted for noticeable share of global Multiplex Assay Market and is projected to experience significant growth in the near future.
The Research & Development segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Bio-Rad Laboratories , Illumina and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Research Analyst at Cognitive Market Research
LinkedIn | Profile | Book Appointment
Supriya Yadav is a skilled market researcher with strong expertise in the Medical Devices and Consumables industry. Known for her analytical precision and deep interest in healthcare innovation, she focuses on decoding key market trends, technological advancements, and evolving customer needs. Supriya excels at transforming complex industry data into meaningful insights that support strategic decision-making for healthcare stakeholders. Her commitment to understanding the future of medical technologies and improving patient-centric solutions makes her a valuable contributor in this rapidly advancing sector.
As a Research Analyst, I bring over two years of experience in market research, data analysis, and market estimation. I specialize in turning complex datasets into meaningful insights that help businesses identify opportunities, understand market dynamics, and make confident, growth-focused decisions.
My expertise spans across analyzing industry trends, forecasting market potential, mapping competitive landscapes, and studying consumer behavior to deliver actionable recommendations. With an MBA in Marketing and Finance, I combine strong analytical skills with strategic thinking, ensuring that every project I work on contributes real value to clients.
I am passionate about using research to uncover patterns, anticipate shifts, and deliver insights that drive measurable business impact. My goal is to continuously learn, innovate, and provide data-driven solutions that empower clients to succeed in a competitive environment.
Global Multiplex Assay Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Multiplex Assay Industry growth. Multiplex Assay market has been segmented with the help of its Type, Application Technology, and others. Multiplex Assay market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
The protein-based multiplex assay segment accounts for the largest market share during the forecast period.
The multiplex assay market is segmented based on type into protein-based multiplex assays and nucleic acid-based multiplex assays. The protein-based multiplex assay segment accounts for the largest market share due to the rising use of proteomics in clinical diagnostics and biomarker research. They have proven to be the fastest and most efficient techniques for protein profiling, thus accelerating the market growth of multiplex assay testing.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Multiplex Assay Industry. Request a Free Sample PDF!
The clinical diagnostics segment holds the largest market share of the multiplex assay market.
Based on application, the multiplex assay market is bifurcated into research & development and clinical diagnostics. The clinical diagnostics segment holds the largest market share due to the increasing prevalence of chronic and infectious diseases. The technical advancements in multiplex assay testing provide early, effective diagnosis and treatment for such diseases. Multiplex assays also give quicker results, detect the sensitivity of the prevailing disease, and simultaneously measure the sample analytes. Therefore, these factors support the adoption of multiplex assay testing in clinical diagnostics.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
The flow cytometry segment is expected to gain the largest market share during the forecast period.
Based on technology, the multiplex assay market is classified into flow cytometry, fluorescence, and luminescence. The flow cytometry segment is expected to gain the largest market share due to the ease of performing multiple assays on a single sample. It offers flexibility even if a large number of samples are analyzed. The results are precise and accurate, given the use of flow cytometry. Therefore, this segment is widely adapted for multiplex assay testing.
Disclaimer:
| Type | Protein-Based Multiplex Assay, Nucleic Acid-Based Multiplex Assay |
| Application | Research & Development, Diagnosis |
| Technology | Flow Cytometry, Fluorescence, Luminescence |
| List of Competitors | Bio-Rad Laboratories, Thermo Fisher Scientific, Illumina, Luminex Corporation, Abcam, Seegene, Merck KGaA, QIAGEN, PerkinElmer, R&D Systems, Assay Genie, Becton, Dickinson and Company |
Chapter 1 2026 Geopolitical Outlook - Multiplex Assay Market Detailed Analysis
This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy
Chapter 2 AI's Impact on Market - Detailed Qualitative Analysis
This chapter will help you gain GLOBAL Market Analysis of Multiplex Assay. Further deep in this chapter, you will be able to review Global Multiplex Assay Market Split by various segments and Geographical Split.
Chapter 3 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Multiplex Assay. Further deep in this chapter, you will be able to review North America Multiplex Assay Market Split by various segments and Country Split.
Chapter 4 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Multiplex Assay. Further deep in this chapter, you will be able to review Europe Multiplex Assay Market Split by various segments and Country Split.
Chapter 5 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Multiplex Assay. Further deep in this chapter, you will be able to review Asia Pacific Multiplex Assay Market Split by various segments and Country Split.
Chapter 6 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Multiplex Assay. Further deep in this chapter, you will be able to review South America Multiplex Assay Market Split by various segments and Country Split.
Chapter 7 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Multiplex Assay. Further deep in this chapter, you will be able to review Middle East Multiplex Assay Market Split by various segments and Country Split.
Chapter 8 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Multiplex Assay. Further deep in this chapter, you will be able to review Middle East Multiplex Assay Market Split by various segments and Country Split.
Chapter 9 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Multiplex Assay. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 10 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 11 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Type Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Application Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 14 Market Split by Technology Analysis 2022 - 2034
Chapter 15 Multiplex Assay Price Trend Analysis
Chapter 16 Multiplex Assay Import/Export Analysis
Chapter 17 Multiplex Assay Production Analysis
Chapter 18 Gap Analysis
Chapter 19 Strategy Analysis
Chapter 20 Profitability and Gross Margin Analysis
Chapter 21 TAM Analysis
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Multiplex Assay market
Chapter 22 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 23 Research Methodology and Sources
1 Data Gathering
2 Data Validation
3 Data Presentation
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for our full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants your team direct access to our lead analysts for bespoke strategic consultation.